—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Lantheus Holdings Inc（LNTH）— 同業公司組

數據截至2026-10-30 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

Lantheus Holdings Inc的Closelook綜合評分為60/100，在同業公司組內排名第1位（共7家）——為組內最高讀數。

名稱綜合動能品質估值訊號距52週高點
LNTH Lantheus Holdings Inc60737355ok10.2%
BHC.TO Bausch Health Companies Inc58867183info9.3%
GALDY GALDERMA GROUP AG57715923ok0.4%
KNSA Kiniksa Pharmaceuticals Ltd57975919ok6.3%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock56935847ok0.8%
IRWD Ironwood Pharmaceuticals Inc55257784warn39.4%
ALM.MC Almirall S.A.54354663info23.2%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-30

Quick answers

Lantheus Holdings Inc在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Ironwood Pharmaceuticals Inc (IRWD)、Almirall S.A. (ALM.MC)。

LNTH相對同業公司的評分如何？

Lantheus Holdings Inc的綜合評分為60/100，組內排名第1位（共7家），截至2026-10-30——為組內最高。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.